Literature DB >> 34006929

The miR-378c-Samd1 circuit promotes phenotypic modulation of vascular smooth muscle cells and foam cells formation in atherosclerosis lesions.

Shengya Tian1, Yang Cao2, Jinliang Wang3, Yongjun Bi4, Jingquan Zhong5, Xiangbin Meng6, Wenyu Sun7, Ruixue Yang5, Luping Gan8, Xuping Wang5, Hongshi Li5, Rong Wang9,10.   

Abstract

MicroRNAs have emerged as key regulators in vascular diseases and are involved in the formation of atherosclerotic lesions. However, the atherosclerotic-specific MicroRNAs and their functional roles in atherosclerosis are unclear. Here, we report that miR-378c protects against atherosclerosis by directly targeting Sterile Alpha Motif Domain Containing 1 (Samd1), a predicted transcriptional repressor. miR-378c was strikingly reduced in atherosclerotic plaques and blood of acute coronary syndrome (ACS) patients relative to healthy controls. Suppression of miR-378c promoted vascular smooth muscle cells (VSMCs) phenotypic transition during atherosclerosis. We also reported for the first time that Samd1 prolonged immobilization of LDL on the VSMCs, thus facilitated LDL oxidation and subsequently foam cell formation. Further, we found that Samd1 contains predicted DNA binding domain and directly binds to DNA regions as a transcriptional repressor. Together, we uncovered a novel mechanism whereby miR-378c-Samd1 circuit participates in two key elements of atherosclerosis, VSMCs phenotypic transition and LDL oxidation. Our results provided a better understanding of atherosclerosis pathophysiology and potential therapeutic management by targeting miR-378c-Samd1 circuit.

Entities:  

Year:  2021        PMID: 34006929     DOI: 10.1038/s41598-021-89981-z

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  55 in total

1.  The fine structure of human atherosclerotic lesions.

Authors:  J C GEER; H C McGILL; J P STRONG
Journal:  Am J Pathol       Date:  1961-03       Impact factor: 4.307

Review 2.  Atherosclerosis: current pathogenesis and therapeutic options.

Authors:  Christian Weber; Heidi Noels
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

Review 3.  Atherosclerosis.

Authors:  Peter Libby; Julie E Buring; Lina Badimon; Göran K Hansson; John Deanfield; Márcio Sommer Bittencourt; Lale Tokgözoğlu; Eldrin F Lewis
Journal:  Nat Rev Dis Primers       Date:  2019-08-16       Impact factor: 52.329

Review 4.  Overview of microRNA biology.

Authors:  Ashley M Mohr; Justin L Mott
Journal:  Semin Liver Dis       Date:  2015-01-29       Impact factor: 6.115

Review 5.  MicroRNA biogenesis pathways in cancer.

Authors:  Shuibin Lin; Richard I Gregory
Journal:  Nat Rev Cancer       Date:  2015-06       Impact factor: 60.716

6.  MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts.

Authors:  Thomas Thum; Carina Gross; Jan Fiedler; Thomas Fischer; Stephan Kissler; Markus Bussen; Paolo Galuppo; Steffen Just; Wolfgang Rottbauer; Stefan Frantz; Mirco Castoldi; Jürgen Soutschek; Victor Koteliansky; Andreas Rosenwald; M Albert Basson; Jonathan D Licht; John T R Pena; Sara H Rouhanifard; Martina U Muckenthaler; Thomas Tuschl; Gail R Martin; Johann Bauersachs; Stefan Engelhardt
Journal:  Nature       Date:  2008-11-30       Impact factor: 49.962

Review 7.  MicroRNAs in atherosclerosis.

Authors:  Ku-Chung Chen; Suh-Hang Hank Juo
Journal:  Kaohsiung J Med Sci       Date:  2012-08-05       Impact factor: 2.744

Review 8.  Vascular smooth muscle cells in atherosclerosis.

Authors:  Gemma L Basatemur; Helle F Jørgensen; Murray C H Clarke; Martin R Bennett; Ziad Mallat
Journal:  Nat Rev Cardiol       Date:  2019-06-26       Impact factor: 32.419

Review 9.  Roles of microRNA on cancer cell metabolism.

Authors:  Bing Chen; Hongbin Li; Xiao Zeng; Pengbo Yang; Xinyu Liu; Xia Zhao; Shufang Liang
Journal:  J Transl Med       Date:  2012-11-20       Impact factor: 5.531

Review 10.  Atherosclerosis: process, indicators, risk factors and new hopes.

Authors:  Mahmoud Rafieian-Kopaei; Mahbubeh Setorki; Monir Doudi; Azar Baradaran; Hamid Nasri
Journal:  Int J Prev Med       Date:  2014-08
View more
  5 in total

1.  Silencing METTL3 Stabilizes Atherosclerotic Plaques by Regulating the Phenotypic Transformation of Vascular Smooth Muscle Cells via the miR-375-3p/PDK1 Axis.

Authors:  Jingquan Chen; Kun Lai; Xi Yong; Hongshun Yin; Zhilong Chen; Haifei Wang; Kai Chen; Jianghua Zheng
Journal:  Cardiovasc Drugs Ther       Date:  2022-06-15       Impact factor: 3.727

2.  Downregulation of microRNA-512-3p enhances the viability and suppresses the apoptosis of vascular endothelial cells, alleviates autophagy and endoplasmic reticulum stress as well as represses atherosclerotic lesions in atherosclerosis by adjusting spliced/unspliced ratio of X-box binding protein 1 (XBP-1S/XBP-1U).

Authors:  Peipei Ge; Mingxiao Gao; Juan Du; Jingbin Yu; Lei Zhang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

3.  Serum miR-497-5p serves as a diagnostic biomarker for acute coronary syndrome and predicts the occurrence of major adverse cardiovascular events after percutaneous coronary intervention.

Authors:  Tao Chen; Xueshan Zhang; Wei Qian; Ran Zhou; Mingyu Su; Yanfeng Ma
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

4.  SAMD1 attenuates antiphospholipid syndrome-induced vascular injury and pregnancy complications.

Authors:  Ran An; Yanqi Yang; Lei Liu; Peiling Li
Journal:  Immun Inflamm Dis       Date:  2022-09

Review 5.  Molecular basis of acute coronary syndrome.

Authors:  Natalya Balashkevich; Maxut Kazymov; Marat Syzdykbayev; Aima Adylova
Journal:  J Res Med Sci       Date:  2022-05-30       Impact factor: 1.985

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.